Optimallyme

OptimallyMe operates in the health optimisation sector, offering a technology platform for personalised health insights. The company, founded in 2022 by CEO Edward van Harmelen, is headquartered in London, UK. The founding was inspired by van Harmelen's personal health journey, which began in 2019 after experiencing low energy levels and diminished results from exercise. His mission involved extensive personal testing—including food intolerance, DNA, and blood tests—and tracking the results, which led him to assemble a team to provide this capability to a wider audience. Before entrepreneurship, van Harmelen worked as a contractor and consultant, where maintaining peak health was directly tied to his ability to work, reinforcing the importance of proactive health management.

The company's core business revolves around direct-to-consumer at-home blood testing kits and a business-to-business offering that includes corporate wellness programs and technical integrations for other enterprises. Revenue is generated through the sale of these test kits and enterprise solutions. The process for individual clients is straightforward: they choose a test, collect a sample at home, and send it to a lab. The results are then populated into a personal, interactive health dashboard. This platform allows users to visualize their biomarker data through features like heat maps, track changes over time, and connect data from wearable smart devices. Based on this consolidated data, the platform's AI-driven tools provide science-backed, personalized recommendations for optimizing mental and physical health across areas like nutrition, fitness, sleep, and mood.

OptimallyMe serves individuals interested in proactive health management as well as corporate clients seeking to enhance employee wellbeing. It also partners with wellness professionals, like fitness coaches, through an affiliate program. The company has established partnerships with entities such as HYROX and the Marylebone Cricket Club and has secured investment from The Players Fund, a venture capital firm led by athletes. The platform is designed to be highly flexible and can be white-labeled for other companies and clinics that lack the resources to develop such technology in-house. Future developments are expected to include a dedicated mobile app, DNA epigenetic tests, and food intolerance testing.

Keywords: health optimisation, personalised health, at-home blood testing, biomarker tracking, corporate wellness, health technology, preventative health, AI health platform, digital health, nutrition insights, fitness optimisation, connected health devices, employee wellbeing programs, D2C health, B2B health solutions, venture capital-backed, health dashboard, data-driven health, wellness platform, personalised recommendations